Abstract
Purpose
Diffuse intrinsic pontine glioma (DIPG) remains the leading cause of death among pediatric brain tumor patients. Its pontine location and aggressive nature make developing effective treatment an ongoing challenge in pediatric oncology. Although studies have found that one of the hallmark features of glioma is immunosuppression, the immune status of DIPG patient is not clearly understood.
Methods
We tested the lymphocyte profile in four radiologically diagnosed DIPG patients. All the four patients did not receive any steroids, radiotherapy, and chemotherapy before the collection of blood.
Results
We found decreased natural killer (NK) cell level and increased B cell level in all four cases.
Conclusion
These findings suggested that decreased NK cells and increased B cells may aid the tumorigenesis and growth seen in DIPG patient. Increased NK and decreased B cells may be the future direction for the treatment of DIPG patient.
References
Lieberman NAP, DeGolier K, Kovar HM et al (2019) Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Neuro Oncol. 21(1):83–94
Qin Z, Richter G, Schüler T, Ibe S, Cao X, Blankenstein T (1998) B cells inhibit induction of T cell-dependent tumor immunity. Nat Med 4(5):627–630
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, L., Yu, H., Xue, Y. et al. Decreased natural killer cells in diffuse intrinsic pontine glioma patients. Childs Nerv Syst 36, 1345–1346 (2020). https://doi.org/10.1007/s00381-020-04665-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-020-04665-9